Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction.
about
Radionuclide techniques for the assessment of myocardial viabilityLow-dose adenosine stress echocardiography: detection of myocardial viabilityChronic ischemic left ventricular dysfunction: from pathophysiology to imaging and its integration into clinical practice.Imaging myocardial metabolic remodeling.Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.Reversible congestive heart failure caused by myocardial hibernationImpact of preoperative positron emission tomography in patients with severely impaired LV-function undergoing surgical revascularization.Non-transplant surgery for heart failure.Diagnostic and prognostic use of stress echocardiography in stable patients.Noninvasive assessment myocardial viability: current status and future directions.Radionuclide Imaging of Viable Myocardium: Is it Underutilized?The non-invasive assessment of hibernating myocardium in ischaemic cardiomyopathy--a myriad of techniques.Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischaemic heart failure.Dobutamine echocardiography predicts functional outcome after revascularisation in patients with dysfunctional myocardium irrespective of the perfusion pattern on resting thallium-201 imaging.Prevalence of myocardial viability assessed by single photon emission computed tomography in patients with chronic ischaemic left ventricular dysfunction.Detection of scarred and viable myocardium using a new magnetic resonance imaging technique: blood oxygen level dependent (BOLD) MRIMyocardial viability and survival in ischemic left ventricular dysfunction.Radionuclide techniques for the assessment of myocardial viability and hibernation.Viable myocardium: how much is enough?Role of F-18 FDG positron emission tomography (PET) in the assessment of myocardial viability.Clinical decision-making and myocardial viability: current perspectives.The heart failure challenge: optimizing medical and surgical managementSurgery for heart failure.Imaging of the failing heart.Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) IMAGE HF Project I-A: study protocol for a randomized controlled trial.Myocardial viability imaging and revascularization in chronic ischemic left ventricular systolic dysfunction.The role of cardiac PET in translating basic science into the clinical arena.PET and PET/CT in cardiovascular disease.Evaluation of myocardial ischemia and viability by noninvasive cardiac imaging.Targeted metabolic imaging to improve the management of heart disease.PET and SPECT in heart failure.Incidental focal FDG uptake in heart is a lighthouse for considering cardiac screening.Recovery of hibernating myocardium: what is the role of surgical revascularization?The Recovery of Hibernating Hearts Lies on a Spectrum: from Bears in Nature to Patients with Coronary Artery Disease.The role of nuclear cardiac imaging in risk stratification of sudden cardiac death.Effect of time-of-flight and point spread function modeling on detectability of myocardial defects in PET.Stress echocardiography for assessing myocardial ischaemia and viable myocardiumRole of PET-CT in the assessment of myocardial viability in patients with left ventricular dysfunction.Dobutamine magnetic resonance imaging as a predictor of myocardial functional recovery after revascularisationMyocardial hibernation and stunning: from physiological principles to clinical practice.
P2860
Q24612196-A53E7DC8-21D3-4C99-A208-E2894CA9A7B8Q24802516-40673415-6DBD-4DB4-BF18-DC94577EAC85Q30439253-312D1030-ECBD-4188-9CC9-02767A9BD187Q30464469-6A3AC337-EE55-4E32-82DA-3697368EB447Q30573782-D8690B56-B8D5-4031-B03F-59998C48A792Q33601833-D9638E32-714E-4D75-A952-AD08E0E03CAAQ33781237-63C042A4-13CA-4F4D-9A12-97A083F6DBAFQ33893887-2C071710-E73E-411B-A3B1-B1267EED3AB3Q34026473-AEA3CEDA-3D6A-4B71-BC5F-BD36A7897C14Q34774619-D0A3AF41-5475-4302-B8CA-D4E4CAB31465Q34892889-2C75A0B6-4345-41FF-8A3E-DE91F3ED49CAQ35150699-2C2B5531-C953-44D6-AB3E-C9A3672F7893Q35366928-E0A26E56-4080-4DB2-A2CB-8787172AB778Q35374136-D4304097-0E68-4694-B9FA-DD8F76B983E4Q35580142-D3FF164D-C9FF-464A-B41D-45C180EC75C9Q35581274-D53FB61D-D644-42A3-BC4C-DBB8B16326DAQ35791994-1435653A-CEEB-4F6B-A598-7CA56AAD612EQ35836570-0CFFC572-AA28-49AF-84DC-1107F4077953Q36014884-B757C233-0A45-41AD-8412-984576579522Q36031580-C0273526-3DDC-41F9-882F-27E0AF0037D7Q36037551-DE8A877A-17F3-43EC-AACD-402A9CF9DAA4Q36575456-5D6B0D4F-A364-413F-81A9-8CB633018AE8Q36745259-28871948-E399-4240-A663-604712C02401Q36902522-19748D38-EB02-4E72-ADCD-51D0D7598201Q37060322-83A8F828-0B8F-4F5B-92E3-E8EE320E333FQ37656286-9244158B-0751-4912-AD41-5E9F081F7ED8Q37875793-09797B4F-63A3-4013-AE16-D9AAECC95B01Q37896144-296C54E9-6757-47F1-9A26-97252A4372C3Q37965658-1D9D3AE7-F975-4CE8-9E05-5D8F1C2C7D89Q37984866-3E15D71F-1B4C-4FA2-94D2-CF4F290AF8BDQ38075810-AE3FC42C-07D9-4326-B9F7-48FD076FEB61Q38094995-18EA2619-B469-47C6-A196-1DE2B2D2B90BQ38282362-416BCB1C-9391-43AC-9F9A-9C950A450B3CQ38462531-42A53035-4AB2-4B5F-B17A-7307283B9EE4Q39548660-8DEE753F-543D-4AB5-8F84-BE53F4BF11CEQ39907366-7514A0A4-9628-4E58-8EE3-5568D79AF0B9Q41344051-62006A17-A570-4535-9642-F3FC5BB7CA83Q41571579-5D2CAB01-5085-436B-9648-FF73E04BF99EQ42040603-CFD79D0C-2A34-44C1-9731-FDBF8E503AAFQ42092326-66B0243C-DB7D-45AC-8E6D-F6899840F591
P2860
Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Value of metabolic imaging wit ...... left ventricular dysfunction.
@en
Value of metabolic imaging wit ...... left ventricular dysfunction.
@nl
type
label
Value of metabolic imaging wit ...... left ventricular dysfunction.
@en
Value of metabolic imaging wit ...... left ventricular dysfunction.
@nl
prefLabel
Value of metabolic imaging wit ...... left ventricular dysfunction.
@en
Value of metabolic imaging wit ...... left ventricular dysfunction.
@nl
P2093
P1476
Value of metabolic imaging wit ...... left ventricular dysfunction.
@en
P2093
L W Stevenson
M Davidson
M F Di Carli
R C Brunken
P304
P356
10.1016/0002-9149(94)90327-1
P407
P577
1994-03-01T00:00:00Z